Jagadeesh, D., Majhail, N. S., He, Y., Ahn, K. W., Litovich, C., Ahmed, S., Aljurf, M., Bacher, U., Badawy, S. M., Bejanyan, N., Cairo, M., Cerny, J., Epperla, N., Farhadfar, N., Freytes, C. O., Gale, R. P., Haverkos, B., Hossain, N., Inwards, D., Kamble, R. T., Kenkre, V. P., Lazarus, H. M., Lazaryan, A., Lekakis, L., Mei, M., Murthy, H. S., Mussetti, A., Nathan, S., Nishihori, T., Olsson, R. F., Ramakrishnan Geethakumari, P., Savani, B. N., Yared, J. A., Fenske, T. S., Kharfan‐Dabaja, M. A., Sureda, A., & Hamadani, M. (2020). outcomes of rituximab‐BEAM versus BEAM conditioning regimen in patients with diffuse large B cell lymphoma undergoing autologous transplantation. Cancer, 126(10), 2279–2287. http://access.bl.uk/ark:/81055/vdc_100103413951.0x00005a